Imran Khan, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 37, Room 1126
- Bethesda, MD 20892
- 240-760-7086
- imran.khan@nih.gov
RESEARCH SUMMARY
Dr. Khan's research focuses on breast cancer brain metastases. He uses in vitro models of the blood-brain barrier to determine the molecular pathways mediating drug permeability into the brain and assess its therapeutic potential in multiple mouse models of breast cancer brain metastases. He is also exploring the role of metastasis suppressor gene (NM23) and antibody drug conjugates (ADCs) in targeting breast cancer metastasis.
Areas of Expertise
Imran Khan, Ph.D.
Biography
Imran Khan, Ph.D.
Dr. Khan holds a Ph.D. in cancer biology from the Indian Institute of Science (IISc.), India. He completed his first postdoctoral training in NIDCR on understanding the role of Near-Infrared Lasers in wound healing. Subsequently, Dr. Khan joined the Patricia Steeg laboratory at the Women's Malignancies Branch and worked on understanding the molecular mechanism of the metastasis suppressor gene (NM23) and characterization of the Blood Tumor Barrier. He was promoted to Staff Scientist in 2020.